Display options
Cite
Chernyak D, Gevorgyan V. ORGANOCOPPER-MEDIATED TWO-COMPONENT . Chem Heterocycl Compd (N Y). 2012;47(12):1516-1526doi: 10.1007/s10593-012-0942-1.
Chernyak, D., & Gevorgyan, V. (2012). ORGANOCOPPER-MEDIATED TWO-COMPONENT . Chemistry of heterocyclic compounds, 47(12), 1516-1526. https://doi.org/10.1007/s10593-012-0942-1
Chernyak, D, and Gevorgyan, V. "ORGANOCOPPER-MEDIATED TWO-COMPONENT ." Chemistry of heterocyclic compounds vol. 47,12 (2012): 1516-1526. doi: https://doi.org/10.1007/s10593-012-0942-1
Chernyak D, Gevorgyan V. ORGANOCOPPER-MEDIATED TWO-COMPONENT . Chem Heterocycl Compd (N Y). 2012 Mar 01;47(12):1516-1526. doi: 10.1007/s10593-012-0942-1. PMID: 24501430; PMCID: PMC3910007.
Copy Download .nbib Format: NLM
Share it on

Chem Heterocycl Compd (N Y). 2012 Mar 01;47(12):1516-1526. doi: 10.1007/s10593-012-0942-1.

ORGANOCOPPER-MEDIATED TWO-COMPONENT .

Chemistry of heterocyclic compounds

D Chernyak, V Gevorgyan

Affiliations

  1. University of Illinois at Chicago, 845 West Taylor St., Chicago 60607, Illinois, USA.

PMID: 24501430 PMCID: PMC3910007 DOI: 10.1007/s10593-012-0942-1

Abstract

Organocuprates efficiently undergo reaction with heterocyclic propargyl mesylates at low temperature to produce N-fused heterocycles. The copper reagent plays a "double duty" in this cascade transformation, which proceeds through an S

Keywords: allenes; cycloisomerization; indolizines; propargyl mesylates; synthetic methods

References

  1. J Org Chem. 2007 May 11;72(10):3896-905 - PubMed
  2. Angew Chem Int Ed Engl. 2007;46(19):3410-49 - PubMed
  3. J Org Chem. 2006 Nov 10;71(23):8755-60 - PubMed
  4. J Am Chem Soc. 2007 Aug 15;129(32):9868-78 - PubMed
  5. J Am Chem Soc. 2007 Jun 27;129(25):7742-3 - PubMed
  6. J Am Chem Soc. 2008 Jan 30;130(4):1440-52 - PubMed
  7. Angew Chem Int Ed Engl. 2002 Aug 16;41(16):2933-5 - PubMed
  8. Chem Soc Rev. 2007 Jul;36(7):1173-93 - PubMed
  9. Org Lett. 2007 Mar 15;9(6):1169-71 - PubMed
  10. J Org Chem. 2005 Mar 18;70(6):2054-9 - PubMed
  11. Curr Med Chem Anticancer Agents. 2004 Jul;4(4):363-78 - PubMed
  12. J Am Chem Soc. 2007 Mar 7;129(9):2438-9 - PubMed
  13. J Am Chem Soc. 2001 Mar 7;123(9):2074-5 - PubMed
  14. Org Lett. 2004 May 13;6(10):1573-5 - PubMed
  15. J Am Chem Soc. 2005 Aug 3;127(30):10500-1 - PubMed
  16. Chem Rev. 2004 May;104(5):2127-98 - PubMed
  17. Mol Cancer Ther. 2009 Dec;8(12):3307-17 - PubMed
  18. J Org Chem. 2007 Sep 28;72(20):7783-6 - PubMed
  19. Org Lett. 2007 Aug 16;9(17):3433-6 - PubMed
  20. Chem Rev. 2004 Jun;104(6):3079-159 - PubMed
  21. J Org Chem. 2004 Aug 20;69(17):5638-45 - PubMed
  22. Org Lett. 2007 Oct 25;9(22):4547-50 - PubMed
  23. Org Lett. 2008 Jun 5;10(11):2307-10 - PubMed
  24. J Am Chem Soc. 2006 Sep 20;128(37):12050-1 - PubMed
  25. Angew Chem Int Ed Engl. 2007;46(21):3931-3 - PubMed
  26. Org Lett. 2004 Apr 1;6(7):1159-62 - PubMed
  27. Bioconjug Chem. 2009 Jun;20(6):1100-11 - PubMed

Publication Types

Grant support